NCT02003625View on ClinicalTrials.gov

Meloxicam vs Placebo for Mobilization

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2019

Study Completion Date

April 30, 2019

Conditions
Non-Hodgkin's LymphomaHodgkin's LymphomaMultiple MyelomaHematopoietic Stem Cells
Interventions
DRUG

GCSF

DRUG

meloxicam

DRUG

Placebo

Trial Locations (1)

02215

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

The Leukemia and Lymphoma Society

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02003625 - Meloxicam vs Placebo for Mobilization | Biotech Hunter | Biotech Hunter